Authors:
OLIVER RE
HEATHERINGTON AC
JONES AF
ROWLAND M
Citation: Re. Oliver et al., A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL INCORPORATING DISPERSION PRINCIPLES TO DESCRIBE SOLUTE DISTRIBUTION IN THE PERFUSED RAT HINDLIMB PREPARATION, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 389-412
Citation: Ia. Nestorov et al., PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF A HOMOLOGOUS SERIESOF BARBITURATES IN THE RAT - A SENSITIVITY ANALYSIS, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 413-447
Citation: Gl. Sirianni et Ks. Pang, ORGAN CLEARANCE CONCEPTS - NEW PERSPECTIVES ON OLD PRINCIPLES, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 449-470
Citation: Wl. Chiou et al., SIMILARITY OR DISCREPANCY IN PHARMACOKINETIC PARAMETER-ESTIMATION BETWEEN BOLUS AND INFUSION STUDIES, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 471-476
Authors:
MELLICK GD
ANISSIMOV YG
BRACKEN AJ
ROBERTS MS
Citation: Gd. Mellick et al., METABOLITE MEAN TRANSIT TIMES IN THE LIVER AS PREDICTED BY VARIOUS MODELS OF HEPATIC ELIMINATION, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 477-505
Citation: Kj. Lui, SAMPLE-SIZE DETERMINATION FOR REPEATED MEASUREMENTS IN BIOEQUIVALENCETEST, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 507-513
Citation: M. Tod et Jm. Rocchisani, COMPARISON OF ED, EID, AND API CRITERIA FOR THE ROBUST OPTIMIZATION OF SAMPLING TIMES IN PHARMACOKINETICS, Journal of pharmacokinetics and biopharmaceutics, 25(4), 1997, pp. 515-537
Authors:
BRESSOLLE F
AUDRAN M
GAREAU R
PHAM TN
GOMENI R
Citation: F. Bressolle et al., COMPARISON OF A DIRECT AND INDIRECT POPULATION PHARMACODYNAMIC MODEL - APPLICATION TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ATHLETES, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 263-275
Authors:
BLAKEY GE
NESTOROV IA
ARUNDEL PA
AARONS LJ
ROWLAND M
Citation: Ge. Blakey et al., QUANTITATIVE STRUCTURE-PHARMACOKINETICS RELATIONSHIPS - I - DEVELOPMENT OF A WHOLE-BODY PHYSIOLOGICALLY-BASED MODEL TO CHARACTERIZE CHANGESIN PHARMACOKINETICS ACROSS A HOMOLOGOUS SERIES OF BARBITURATES IN THERAT, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 277-312
Authors:
STAGNI G
SHEPHERD AMM
LJU YJ
GILLESPIE WR
Citation: G. Stagni et al., NEW MATHEMATICAL IMPLEMENTATION OF GENERALIZED PHARMACODYNAMIC MODELS- METHOD AND CLINICAL-EVALUATION, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 313-348
Citation: G. Stagni et al., BIOAVAILABILITY ASSESSMENT FROM PHARMACOLOGICAL DATA - METHOD AND CLINICAL-EVALUATION, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 349-362
Citation: M. Weiss, ON THE DEGREE OF SOLUTE MIXING IN LIVER MODELS OF DRUG ELIMINATION, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 363-375
Authors:
MESNIL F
DUBRUC C
MENTRE F
HUET S
MALLET A
THENOT JP
Citation: F. Mesnil et al., PHARMACOKINETIC ANALYSIS OF MIZOLASTINE IN HEALTHY-YOUNG VOLUNTEERS AFTER SINGLE ORAL AND INTRAVENOUS DOSES - NONCOMPARTMENTAL APPROACH ANDCOMPARTMENTAL MODELING, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 125-147
Authors:
COSSON VF
FUSEAU E
EFTHYMIOPOULOS C
BYE A
Citation: Vf. Cosson et al., MIXED EFFECT MODELING OF SUMATRIPTAN PHARMACOKINETICS DURING DRUG DEVELOPMENT .1. INTERSPECIES ALLOMETRIC SCALING, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 149-167
Citation: Tc. Krejcie et al., A RECIRCULATORY MODEL OF THE PULMONARY UPTAKE AND PHARMACOKINETICS OFLIDOCAINE BASED ON ANALYSIS OF ARTERIAL AND MIXED VENOUS DATA FROM DOGS, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 169-190
Citation: Se. Kern et Dr. Westenskow, PHARMACOKINETIC-BASED MINIBOLUS DELIVERY AS AN ALTERNATIVE TO CONTINUOUS-INFUSION FOR DRUGS THAT EXHIBIT A BIOPHASE LAG, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 191-208
Citation: Gl. Rosner et P. Muller, BAYESIAN POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSES USING MIXTURE-MODELS, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 209-233
Citation: J. Wakefield et S. Walker, BAYESIAN NONPARAMETRIC POPULATION-MODELS - FORMULATION AND COMPARISONWITH LIKELIHOOD APPROACHES, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 235-253
Citation: M. Weiss, ERRORS IN CLEARANCE ESTIMATION AFTER BOLUS INJECTION AND ARTERIAL SAMPLING - NONEXISTENCE OF A CENTRAL COMPARTMENT, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 255-260
Authors:
ROBERTS MS
LIPSCHITZ S
CAMPBELL AJ
WANWIMOLRUK S
MCQUEEN EG
MCQUEEN M
Citation: Ms. Roberts et al., MODELING OF SUBCUTANEOUS ABSORPTION KINETICS OF INFUSION SOLUTIONS INTHE ELDERLY USING TECHNETIUM, Journal of pharmacokinetics and biopharmaceutics, 25(1), 1997, pp. 1-21
Citation: Yl. Zhu et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF DOXACURIUM - EFFECT OF INPUT RATE, Journal of pharmacokinetics and biopharmaceutics, 25(1), 1997, pp. 23-37
Citation: B. Tuk et al., THE IMPACT OF ARTERIOVENOUS CONCENTRATION DIFFERENCES ON PHARMACODYNAMIC PARAMETER ESTIMATES, Journal of pharmacokinetics and biopharmaceutics, 25(1), 1997, pp. 39-62
Citation: O. Borga et B. Borga, SERUM-PROTEIN BINDING OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A COMPARATIVE-STUDY, Journal of pharmacokinetics and biopharmaceutics, 25(1), 1997, pp. 63-77
Citation: Je. Bennett et al., MODELING OF TROUGH PLASMA BISMUTH CONCENTRATIONS, Journal of pharmacokinetics and biopharmaceutics, 25(1), 1997, pp. 79-106